{"id":131618,"date":"2023-06-07T08:30:26","date_gmt":"2023-06-07T08:30:26","guid":{"rendered":"https:\/\/ccs.ca\/?post_type=guideline&p=131618"},"modified":"2023-06-07T08:30:43","modified_gmt":"2023-06-07T08:30:43","slug":"chapter-10-flying-dvt-prophylaxis","status":"publish","type":"guideline","link":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-10-flying-dvt-prophylaxis\/","title":{"rendered":"10. Flying: DVT Prophylaxis"},"content":{"rendered":"
Recommendation for DVT Prophylaxis with Long-duration Air Travel*<\/p>
* Literature supports 12 hours as threshold for risk of developing thromboembolism but many would consider 9 hours long haul.<\/p>\n\n\n\n
** Moderate risk: healthy people age > 75, women > 45 taking estrogen containing hormone replacement therapy, pregnant and postpartum women, people up to age 45 who are heterozygous carriers of mutations for Factor V Leiden and Prothrombin gene mutation, varicose veins, heart failure, myocardial infarction within previous 6 weeks, recent lower limb trauma within 6 weeks.<\/p>\n\n\n\n
*** High risk: history of previous VTE, recent major surgery (within 6 weeks), active malignancy, gross obesity or marked immobility due to neuromuscular or cardiorespiratory disease, people age >45 with deficiencies of antithrombin, protein C or protein S, people age >75 with cardiac or pulmonary disease (8,9).<\/p>\n","protected":false},"featured_media":0,"parent":131566,"menu_order":9,"template":"guideline-chapter.php","topic":[],"resource_type":[],"acf":[],"yoast_head":"\n